Cresset Asset Management
RDY icon

Cresset Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Cresset Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-49,330
Closed -$784K – 2123
2024
Q3 		$784K Buy
49,330
+415
+0.8% +$6.68K ﹤0.01% 1289
2024
Q2 		$745K Buy
48,915
+4,915
+11% +$70.4K ﹤0.01% 1234
2024
Q1 		$646K Buy
44,000
+9,430
+27% +$138K ﹤0.01% 1209
2023
Q4 		$481K Buy
34,570
+6,275
+22% +$83.9K ﹤0.01% 1255
2023
Q3 		$378K Buy
28,295
+3,615
+15% +$48.9K ﹤0.01% 1324
2023
Q2 		$312K Buy
+24,680
New +$288K ﹤0.01% 1506
2021
Q4 		– Sell
-18,785
Closed -$244K – 1273
2021
Q3 		$244K Buy
18,785
+265
+1% +$3.53K ﹤0.01% 944
2021
Q2 		$272K Sell
18,520
-5
-0% -$70 ﹤0.01% 824
2021
Q1 		$228K Buy
18,525
+710
+4% +$9.12K ﹤0.01% 805
2020
Q4 		$254K Buy
17,815
+2,005
+13% +$27K ﹤0.01% 615
2020
Q3 		$220K Buy
+15,810
New +$188K ﹤0.01% 611
2019
Q2 		– Sell
-1,170
Closed -$9K – 1403
2019
Q1 		$9K Buy
+1,170
New +$8.89K ﹤0.01% 1205

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Cresset Asset Management's RDY Position: Q4 2024 in Review

Cresset Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 49,330 shares — an estimated $784K sold.

Cresset Asset Management first reported a position in RDY in Q1 2019 and held it in 12 quarters. The position peaked at $784K in Q3 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Cresset Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 49,330 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $784K.
  • Cresset Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 12 quarters.
  • Cresset Asset Management's Dr. Reddy's Laboratories position peaked at $784K in Q3 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.